USA - November 20 2017
The US Food and Drug Administration recently issued warning letters to four companies - Stanley Brothers Social Enterprises LLC, Greenroads Health…
Brian J. Malkin, James R. Ravitz
USA - September 8 2017
Last week, FDA Commissioner Gottlieb issued a statement describing the Agency’s “new” policy for regulating stem cell therapies and regenerative…
Naomi J. L. Halpern, James R. Ravitz
USA - October 6 2017
In August 2016, the Food and Drug Administration issued a final rule to update and clarify the agency’s drug registration and listing regulations. The…
Stephanie Trunk
USA - February 16 2017
Last month, Baxter International Inc. and Baxter Healthcare Corporation (collectively “Baxter”) settled a qui tam False Claims Act (FCA) case with…
Stephanie Trunk
USA - April 18 2016
The US Drug Enforcement Administration recently announced that it is evaluating whether to downgrade the classification of marijuana under the…
James H. Hartten, James R. Ravitz